
Northwell Depth-Dose Study to be presented at AAPM!
Northwell depth-dose study to be presented at the AAPM annual meeting.

Northwell depth-dose study to be presented at the AAPM annual meeting.

Pilot production begins at Liberty Vision.

Liberty Vision CEO Dr. Paul T. Finger contributes to a new book on surgical ophthalmic oncology.
Liberty Vision secures larger facilities to support growing operations.

Testing and qualification of device production and processes is underway.

Several key US patents granted for the iWand® device, its key technologies, and variants.